Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages
✍ Scribed by Roseann M. Glaser; Ann Marshak-Rothstein
- Book ID
- 102823298
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 933 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Lethally irradiated MRL/lpr mice reconstituted with T cell‐depleted bone marrow stem cells from the non‐autoimmune strain A. Thy had been shown to develop a state of long‐term split chimerism; erythrocytes were derived from the A. Thy donor, while peripheral lymphocytes were derived from the lpr recipient. In contrast, recipients of the non‐lpr‐congenic strain, MRL/+, were fully repopulated in both lineages by donor‐derived hematopoietic cells. In order to more fully understand the mechanisms responsible for this type of split chimerism, we have investigated additional genetic and developmental parameters. We found that histocompatible normal B cell precursors engrafted C3H/HeJ and C57BL/6/+ mice much better than they engrafted the corresponding lpr congenic strains, indicating that resistance to lymphoid engraftment was not unique to the MRL background. Bone marrow cells and peritoneal macrophages were found to express the donor H‐2 phenotype in both non‐lpr and lpr recipients, limiting resistance to the lymphoid lineage. Moreover, we showed that normal bone marrow stem cells passaged in an lpr host environment were subsequently able to repopulate the B cell lineage of non‐lpr secondary recipients, proving that prelymphoid stem cells were intact. Although lymph node cells from A. Thy → MRL/lpr chimeras were lpr‐derived, they did not show the abnormal surface marker expression associated with the lpr phenotype, nor did they develop lymphoid hyperplasia or elevated autoantibody levels. However, A. Thy → MRL/lpr chimeras differed from normal mice in that their spleens were markedly deficient in IgM^+^ B cells.